ATE204604T1 - Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen - Google Patents

Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen

Info

Publication number
ATE204604T1
ATE204604T1 AT94114212T AT94114212T ATE204604T1 AT E204604 T1 ATE204604 T1 AT E204604T1 AT 94114212 T AT94114212 T AT 94114212T AT 94114212 T AT94114212 T AT 94114212T AT E204604 T1 ATE204604 T1 AT E204604T1
Authority
AT
Austria
Prior art keywords
heparin binding
binding site
growth factors
fibroblast growth
analogues
Prior art date
Application number
AT94114212T
Other languages
German (de)
English (en)
Inventor
Lu-Yuan Li
Andrew Peter Seddon
Yakov Gluzman
Peter Bohlen
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE204604T1 publication Critical patent/ATE204604T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT94114212T 1993-09-24 1994-09-09 Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen ATE204604T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12697493A 1993-09-24 1993-09-24

Publications (1)

Publication Number Publication Date
ATE204604T1 true ATE204604T1 (de) 2001-09-15

Family

ID=22427669

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94114212T ATE204604T1 (de) 1993-09-24 1994-09-09 Strukturanaloge von fibroblasten- wachstumsfaktoren, die eine modifizierte heparin- bindungsstelle aufweisen

Country Status (13)

Country Link
EP (1) EP0645451B1 (https=)
JP (1) JPH07149797A (https=)
KR (1) KR100320803B1 (https=)
AT (1) ATE204604T1 (https=)
AU (1) AU680533B2 (https=)
CA (1) CA2132668A1 (https=)
DE (1) DE69428013T2 (https=)
DK (1) DK0645451T3 (https=)
ES (1) ES2161233T3 (https=)
NZ (1) NZ264529A (https=)
PT (1) PT645451E (https=)
TW (1) TW275068B (https=)
ZA (1) ZA947454B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
WO1999055861A2 (en) * 1998-04-28 1999-11-04 Eisai Co., Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
WO2011130729A2 (en) 2010-04-16 2011-10-20 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf
WO2013131091A1 (en) 2012-03-02 2013-09-06 New York University Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders
US9464126B2 (en) * 2012-06-07 2016-10-11 New York University Chimeric fibroblast growth factor 21 proteins and methods of use
US9657075B2 (en) 2012-06-07 2017-05-23 New York University Chimeric fibroblast growth factor 23 proteins and methods of use
US9474785B2 (en) * 2012-06-07 2016-10-25 New York University Chimeric fibroblast growth factor 19 proteins and methods of use
US9550820B2 (en) 2013-02-22 2017-01-24 New York University Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
AU2014340241B2 (en) 2013-10-21 2018-11-01 Salk Institute For Biological Studies Mutated fibroblast growth factor (FGF) 1 and methods of use
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
EP3368059A4 (en) 2015-10-30 2019-03-27 Salk Institute for Biological Studies TREATMENT OF STEROID-INDUCED HYPERGLYCEMIA WITH FIBROBLAST GROWTH FACTOR (FGF) -1 ANALOGUE
KR20170109207A (ko) * 2016-03-17 2017-09-28 중앙대학교 산학협력단 화학반응을 통하여 결합된 섬유아세포 증식인자-헤파린 복합체 및 이의 제조 방법
US11229681B2 (en) * 2017-07-14 2022-01-25 The Regents Of The University Of California Dominant-negative FGF2 antagonists
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
CN116042681A (zh) * 2022-08-01 2023-05-02 普纳思细胞(厦门)生物科技有限公司 一种bFGF热稳定性改造的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2879148B2 (ja) * 1987-07-07 1999-04-05 サイオス インコーポレイテッド 組換え繊維芽細胞成長因子
WO1989004832A1 (en) * 1987-11-24 1989-06-01 Amgen Inc. Analogs of fibroblast growth factor
GB8821795D0 (en) * 1988-09-16 1988-10-19 Erba Carlo Spa New derivatives of human/bovine basic fibroplast growth factor

Also Published As

Publication number Publication date
ZA947454B (en) 1995-05-15
DE69428013D1 (de) 2001-09-27
DE69428013T2 (de) 2002-05-29
NZ264529A (en) 1997-06-24
EP0645451A1 (en) 1995-03-29
CA2132668A1 (en) 1995-03-25
AU680533B2 (en) 1997-07-31
EP0645451B1 (en) 2001-08-22
JPH07149797A (ja) 1995-06-13
AU7418594A (en) 1995-04-06
KR100320803B1 (ko) 2002-06-20
ES2161233T3 (es) 2001-12-01
PT645451E (pt) 2001-12-28
DK0645451T3 (da) 2001-10-08
TW275068B (https=) 1996-05-01

Similar Documents

Publication Publication Date Title
DE69428013D1 (de) Strukturanaloge von Fibroblasten-Wachstumsfaktoren, die eine modifizierte Heparin-Bindungsstelle aufweisen
DE69019578D1 (de) Baustahl mit hoher Festigkeit und guter Bruchzähigkeit.
ATE109163T1 (de) Sulfaminoderivate von chondroitinsulfat, dermatansulfat und hyaluronsäure und ihre pharmakologischen eigenschaften.
ATE108459T1 (de) Antagonisten des fibroblasten-wachstumsfaktors.
DE59010194D1 (de) Gitter für die Osteosynthese oder zum Befestigen von künstlichen Körperteilen
ATE125867T1 (de) Fibronektinbindungsprotein und dessen herstellung.
DE68916512D1 (de) Zusammensetzung zur Verminderung von postoperativen Adhäsionen und ihre Verwendung.
DE69019412D1 (de) Absorptionsmikroskopie und/oder -spektroskopie mit Abtastmikroskopiesteuerung.
ATE209707T1 (de) Aushärtbare legierung mit einer kombination von hoher festigkeit und guter zähigkeit
NO177514C (no) Lavtaps, analog faseforskyver med nesten 360 ing i X-båndet
ATE37413T1 (de) Stahltraeger.
KR900702027A (ko) 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체
DE69718359D1 (de) Verankerungsschaft, insbesondere zur Verwendung in Prothesen
ES2016960B3 (es) Hidrociclon o piezas de hidrociclon, asi como procedimiento para su fabricacion
DE59508490D1 (de) Verfahren, Systemkomponente und Programm-Modul zur Auswahl eines Suchbegriffs
DE69001213D1 (de) Brueckensystem zur ueberwindung von graeben durch fahrzeuge.
ATE47402T1 (de) Verfahren zur herstellung von mukopolysaccharidzusammensetzungen welche eine hohe antithrombogene aktivitaet besitzen.
SE8702813L (sv) Ortos
ES2075784A2 (es) Procedimiento para la construccion de tableros de tipo cajon, para puentes, con vigas en u.
ES1040478U (es) Mesa de sujecion para trabajos en general.
ATE25573T1 (de) Anordnung in einem betaetiger zur hoeheneinstellung von arbeitsbuehnen.
ES1003876U (es) Soporte para el corte de lena perfeccionado.
ES1014611U (es) Pata perfeccionada para mesas.
ES1004218U (es) Parque infantil
ATA278186A (de) Antriebslagerung zur aufnahme von vertikallasten, insbesondere bei federrollenmuehlengetrieben

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee